FDA's new mammogram guidelines recommending additional screening for some patients could help detect breast cancer earlier
The new requirements, finalized Thursday by the Food and Drug Administration, are aimed at standardizing the information given to millions of women following scans to detect breast cancer to include recommendations they speak with their doctor about undergoing additional screening.
“Today’s action represents the agency’s broader commitment to support innovation to prevent, detect and treat cancer,” Dr. Hilary Marston, the FDA’s chief medical officer,Regulators first proposed the changes in 2019 and healthcare providers will have 18 months to comply with the policy.About half of women over age 40 have dense breasts, with less fatty tissue and more connective and glandular tissue.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
New mammogram guidelines could help more women detect breast cancer earlierThe updated guidelines could potentially help more women detect breast cancer earlier.
続きを読む »
FDA sets national mammogram standards to protect women with dense breastsMammogram providers will be required to inform women with dense breast tissue that their cancer screenings may be difficult to interpret and recommend consulting their doctors about the need for additional tests, the Food and Drug Administration announced.
続きを読む »
Doctor talks about new FDA-approved blood test for diagnosing concussionsThe FDA has cleared a blood test to diagnosis a concussion, which is big deal for doctors and patients.
続きを読む »
Latin American Complementary Feeding Guidelines UpdatedRepresentatives of 21 countries with different traditions and cultures collaborated on the new consensus.
続きを読む »
Albuterol Shortage Challenges Hospitals Treating Patients With Breathing ProblemsHospitals are running out of a liquid form of albuterol, a medication used to treat people with breathing problems, weeks after the only maker of the product declared bankruptcy
続きを読む »
U.S. FDA clears Abbott's blood test for concussionsThe clearance marks the first commercially available laboratory blood test for TBI, according to the company, helping the doctors to rule out need for a CT scan in patients with mild TBI. TBIs are caused by blow or whiplash to the head and can pose risk of short- and long-term effects that can include impairment of memory and movement. Abbott already has a plasma test for TBI and was cleared by the FDA in 2021.
続きを読む »